266 related articles for article (PubMed ID: 30909922)
1. High cure rates and tolerability of artesunate-amodiaquine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania.
Mandara CI; Francis F; Chiduo MG; Ngasala B; Mandike R; Mkude S; Chacky F; Molteni F; Njau R; Mohamed A; Warsame M; Ishengoma DS
Malar J; 2019 Mar; 18(1):99. PubMed ID: 30909922
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
Kakolwa MA; Mahende MK; Ishengoma DS; Mandara CI; Ngasala B; Kamugisha E; Kataraihya JB; Mandike R; Mkude S; Chacky F; Njau R; Premji Z; Lemnge MM; Warsame M; Menard D; Kabanywanyi AM
Malar J; 2018 Oct; 17(1):369. PubMed ID: 30333022
[TBL] [Abstract][Full Text] [Related]
3. High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania.
Mandara CI; Kavishe RA; Gesase S; Mghamba J; Ngadaya E; Mmbuji P; Mkude S; Mandike R; Njau R; Mohamed A; Lemnge MM; Warsame M; Ishengoma DS
Malar J; 2018 Jul; 17(1):261. PubMed ID: 29996849
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
6. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018.
Ngasala B; Chiduo MG; Bushukatale S; Mmbando BP; Makene T; Kamugisha E; Ahmed M; Mandara CI; Francis F; Mahende MK; Kavishe RA; Muro F; Ishengoma DS; Mandike R; Molteni F; Chacky F; Kitojo C; Greer G; Bishanga D; Chadewa J; Njau R; Warsame M; Kabula B; Nyinondi SS; Reaves E; Mohamed A
Malar J; 2024 Apr; 23(1):95. PubMed ID: 38582830
[TBL] [Abstract][Full Text] [Related]
8. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
[TBL] [Abstract][Full Text] [Related]
9. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
[TBL] [Abstract][Full Text] [Related]
10. Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children.
Nji AM; Ali IM; Moyeh MN; Ngongang EO; Ekollo AM; Chedjou JP; Ndikum VN; Evehe MS; Froeschl G; Heumann C; Mansmann U; Ogundahunsi O; Mbacham WF
Malar J; 2015 Jan; 14():27. PubMed ID: 25626448
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2019.
Ngasala BE; Chiduo MG; Mmbando BP; Francis FT; Bushukatale S; Makene T; Mandara CI; Ishengoma DS; Kamugisha E; Ahmed M; Mahende MK; Kavishe RA; Muro F; Molteni F; Reaves E; Kitojo C; Greer G; Nyinondi S; Kabula B; Lalji S; Chacky F; Njau RJ; Warsame M; Mohamed A
Malar J; 2024 Apr; 23(1):101. PubMed ID: 38594679
[TBL] [Abstract][Full Text] [Related]
12. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam.
Thanh NX; Trung TN; Phong NC; Quang HH; Dai B; Shanks GD; Chavchich M; Edstein MD
Malar J; 2012 Jun; 11():217. PubMed ID: 22741618
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.
Plucinski MM; Dimbu PR; Macaia AP; Ferreira CM; Samutondo C; Quivinja J; Afonso M; Kiniffo R; Mbounga E; Kelley JS; Patel DS; He Y; Talundzic E; Garrett DO; Halsey ES; Udhayakumar V; Ringwald P; Fortes F
Malar J; 2017 Feb; 16(1):62. PubMed ID: 28153004
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
[TBL] [Abstract][Full Text] [Related]
16. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique.
Nhama A; Bassat Q; Enosse S; Nhacolo A; Mutemba R; Carvalho E; Naueia E; Sevene E; Guinovart C; Warsame M; Sanz S; Mussa A; Matsinhe G; Alonso P; Tiago A; Macete E
Malar J; 2014 Aug; 13():309. PubMed ID: 25108397
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger.
Grandesso F; Guindo O; Woi Messe L; Makarimi R; Traore A; Dama S; Laminou IM; Rigal J; de Smet M; Ouwe Missi Oukem-Boyer O; Doumbo OK; Djimdé A; Etard JF
Malar J; 2018 Jan; 17(1):52. PubMed ID: 29370844
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013.
Dorkenoo AM; Yehadji D; Agbo YM; Layibo Y; Agbeko F; Adjeloh P; Yakpa K; Sossou E; Awokou F; Ringwald P
Malar J; 2016 Jun; 15():331. PubMed ID: 27334876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
